*Discussion points and the recording of this meeting have been published. (December 24 , 2024)

On March 5, 2024, Health and Global Policy Institute (HGPI) Manager Ms. Yui Kohno presented at the UK-Japan Multistakeholder Meeting “The Future of AMR – Policy and Investment”, hosted by the British Embassy Tokyo and supported by HGPI.

This meeting was held with the overarching theme of the links between policy, investment, and science in AMR. Views of the United Kingdom (UK) and Japan were presented with topics that touched on Japan’s policy and future plans for tackling AMR and how to get the most out of the UN high-level meeting this year. Following the presentations, panelists discussed 1) The role of policymakers in tackling AMR and developing antimicrobials and 2) How best to invest for the future of AMR. Participants of the meeting included policymakers, academic societies, clinicians, industry, and civil society experts from Japan and the UK.

Discussion Points

Point 1: To effectively promote AMR countermeasures both domestically and internationally, the government must strengthen inter-ministerial and international collaboration. Ensuring alignment between the legislative branch, as policymakers, and civil society is critical for sustaining promotion in the future. By fostering this alignment, we can increase effort to address democratizing AMR challenges.

Point 2: Encouraging greater information disclosure and transparency is expected to drive increased private sector investment in AMR countermeasures. Drawing from the example of climate change countermeasures initiatives, it is essential to develop frameworks and foster social values that assess and evaluate the contribution of each company’s AMR efforts.

Point 3: Guided by ongoing international discussions, recognizing AMR as an urgent global issue, countermeasures must be prioritized and implemented without delay. Addressing AMR requires comprehensive investment—not just financial resources, but also time, skilled human resources, and technological innovation.

For details, please view the PDF provided bottom.

[Program] (Titles omitted)

16:15-16:20	Opening Remarks
	Margaret Tongue (Minister-Counsellor, British Embassy Tokyo)
16:20-16:50	Keynote Lectures
	Lecture 1 “Links between policy, investment and science on AMR”
	Kazuhiro Tateda (Professor, Department of Microbiology and Infectious Diseases, Toho University)
	Lecture 2 “Japan’s policy and future plans for tackling AMR”
	Eiji Hinoshita (Assistant Minister for Global Health and Welfare, Ministry of Health, Labour and Welfare (MHLW), Japan)
	Lecture 3 “How to get the most out of the UN HLM”
	Dame Sally Davies (Special Envoy on Antimicrobial Resistance for the United Kingdom)
17:00-17:45	Panel Discussion
	Panelists: Kenji Fuma (CEO & Founder, Neural Inc.) Yui Kohno (Manager, Health and Global Policy Institute) Alicia Demirjian (UK Health Security Agency (UKHSA) / Consultant, Evelina London Children’s Hospital) Claire Oxlade (Private Secretary to the UK Special Envoy on Antimicrobial Resistance, Dame Sally Davies / Department of Health and Social Care, UK) Gerald Bloom (Fellow, The Institute of Development Studies (IDS)) Moderator: Margaret Tongue (Minister-Counsellor, British Embassy Tokyo)
17:45-18:00	Closing Remarks
	Yasuhisa Shiozaki (Member of the Global Leaders Group on Antimicrobial Resistance / Former Minister of Health, Labour and Welfare)

◼︎The Recording of the Meeting